Synopsis: Weight loss drugs such as Ozempic mimic the naturally occurring hormone GLP-1, which the intestine releases after meals to signal fullness and help the pancreas release insulin
It is prescribed based on BMI and weight-related health conditions
Lipolysis is the process of converting TG into glycerol and fatty acids under the action of hydrolase, such as adipose triacylglyceride lipase (ATGL), hormone-sensitive lipase (HSL), and monacylglycerol lipase, in which fatty acids can provide energy for the body through -oxidation or other oxidation pathways
This raises questions about dosage adjustments over time that the standard escalation charts do not address
Improved Insulin Sensitivity: GIP synergizes with GLP-1 to enhance insulin sensitivity in skeletal muscle and liver, reducing insulin resistance and mitigating weight rebound caused by hyperinsulinemia
It is not approved for medical or personal use in the UK